← Back

Wire · opportunities

Bayer wins FDA nod for a new kind of blood thinner

Published

10 November 2026

Topic

opportunities

◆ Sectors

Drug Discovery

◆ Geography

United States

◆ Source

Read at biopharmadive.com →

◆ Verified

Fusion42 · 10 November 2026 · Fusion42 review

Bayer received FDA approval for Sunharbo, a new type of blood thinner classified as a Factor XIa inhibitor, which represents a novel class of stroke prevention medication.

This Wire brief sits within Fusion42's coverage of Drug Discovery, and 3 sources have reported it.

◆ ◆ The Wire takeaway

You can now build on a new FDA-approved drug class that may change stroke prevention treatment standards and open up new competitive opportunities.

◆ Coverage

3 sources · 10 Nov 2026

◆ Related on Wire

◆ Topics

Drug Discoveryfda-approvalblood-thinnerstroke-preventionfactor-xia-inhibitorbayer